| Literature DB >> 36192250 |
Emily Gray1, Constance Hardwick2, Nicola Gradwell3, Annie Pellatt3, Naomi Cassells4, Rachael Craven4, Jacqueline Cox3, Tom Dudding5.
Abstract
On the 25 March 2020 the Chief Dental Officer (CDO) published guidance to restrict the provision of routine dental care in England due to the rapid spread of the severe acute respiratory syndrome Coronavirus 2 (COVID-19). We analysed the impact of the pandemic on the number of patients presenting with odontogenic pain and infection to the emergency department (ED) of an urban-based teaching hospital, the Bristol Royal Infirmary (BRI). Furthermore, we investigated the severity of infection at first presentation to the ED. The study period encompassed three phases that represented the stages of pandemic restrictions: phase 1 prior to lockdown measures, with no restrictions to dental practice; phase 2 during the government lockdown, with the severest restrictions on dental practices; and phase 3 following the ease of lockdown measures, with return to limited dental services. Data was collected retrospectively from electronic patient records (EPR) regarding adult patients presenting to the ED with dental pain. The rate of presentations (per week) was calculated for each timepoint and compared. A severity score was assigned to each patient using a grading system based on signs of clinical infection and treatment modality. Patients' presentations were analysed at each phase of the pandemic. There was a 42.8% increase in attendance with oral facial pain and infection to ED from phases 1 to 3. The COVID-19 pandemic resulted in restrictions to routine primary dental care services, which were deemed necessary to reduce the spread of the virus. However, this increased demand on secondary care services, as patients increasingly struggled to access primary dental care to manage dental pain.Entities:
Keywords: COVID-19; Dental pain; Emergency department; Odontogenic infection; Secondary care
Year: 2022 PMID: 36192250 PMCID: PMC9525200 DOI: 10.1016/j.bjoms.2022.07.006
Source DB: PubMed Journal: Br J Oral Maxillofac Surg ISSN: 0266-4356 Impact factor: 2.018
Data collection for each presentation to the emergency department.
| Variable | Parameter |
|---|---|
| Anonymous identifier | |
| Age | |
| Sex | Male/Female |
| Referral source | Emergency department/Bristol Dental Hospital |
| Regular dental attender | Yes/No/Unknown |
| Previous general dental practitioner visit prior to emergency department attendance | Yes/No |
| Previous general medical practitioner visit prior to emergency department attendance | Yes/No |
| Previous antibiotic prescription | Yes/No |
| Comorbidities | Diabetes, smoking, immunocompromised |
| Medication | Steroids, anticoagulants, immunosuppressants, other, none |
| Allergies | Yes/No |
| Systemic involvement | None, lymphadenopathy, neck swelling, trismus, dysphonia/dysphagia, bilateral neck swelling/Ludwig’s angina |
| Infection site | |
| Ludwig’s angina | Yes/No |
| Return to theatre | Yes/No |
| ITU admission | Yes/No |
| Previous analgesic use | Paracetamol, ibuprofen, paracetamol and ibuprofen, codeine, codeine and paracetamol, other, none |
| Previous dental treatment | None, extirpation, temporary restoration, incision and drainage, extraction under local anaesthesia |
| Sepsis six trigger | Yes/No |
| Route of antibiotic prescribed in secondary care | Oral and discharge from emergency department, IV in emergency department and discharge, IV and admit |
| Treatment | No treatment, analgesic advice, discharge and dentist to treat, extraction under local anaesthesia, incision and drainage under local anaesthesia, treatment under general anaesthesia |
Number of attendances to the emergency department for dental pain and or infection during the different phases of primary dental service restrictions due to COVID-19. Data are number.
| Phase | Number of presentations seen at BRI | Number of days in phase | Number of weeks in phase | Average number of presentations/weeks | Mean difference pre and post COVID-19 restrictions |
|---|---|---|---|---|---|
| Phase 1 | 101 | 84 | 11.8 | 8.5 | |
| Phase 2 | 117 | 75 | 10.7 | 10.9 | |
| Phase 3 | 364 | 208 | 29.8 | 12.2 | |
| After COVID-19 restrictions | 481 | 283 | 40.5 | 11.8 | 3.07 |
Severity score/phase of COVID-19 restrictions to primary dental care. Data are No. (%).
| Variables | Phase 1 | Phase 2 | Phase 3 | Post COVID-19 restrictions (phases 2 and 3) | Total |
|---|---|---|---|---|---|
| Systemic score: | |||||
| No sign of systemic involvement (score = 0) | 82 (81.2) | 100 (85.5) | 298 (81.9) | 398 (82.7) | 480 (82.5) |
| Lymphadenopathy (score = 1) | 0 | 3 (2.6) | 4 (1.1) | 7 (1.5) | 7 (1.2) |
| Trismus (score = 2) | 12 (11.9) | 7 (5.9) | 44 (12.1) | 51 (10.6) | 63 (10.8) |
| Major neck swelling (score = 3) | 0 | 0 | 0 | 0 | 0 |
| Dysphagia/dysphonia (score = 4) | 7 (6.9) | 7 (5.9) | 15 (4.1) | 22 (4.6) | 29 (4.9) |
| Bilateral neck swelling/Ludwig’s angina (score = 5) | 0 | 0 | 3(0.8) | 3 (0.6) | 3 (0.5) |
| Total | 101 | 117 | 364 | 481 | 582 |
| Mean score | 0.51 | 0.38 | 0.46 | 0.44 | 0.45 |
| Treatment score: | |||||
| No treatment (score = 0) | 18 (17.8) | 8 (6.8) | 41 (11.2) | 49 (10.2) | 67 (11.5) |
| Analgesic advice/GDP to treat/referral to BDH (score = 1) | 53 (52.5) | 79 (67.5) | 237 (65.1) | 316 (65.7) | 369 (63.4) |
| Extraction with LA (score = 2) | 0 | 1 (0.9) | 0 | 1 (0.2 | 1 (0.2 |
| Incision and drainage LA (score = 3) | 15 (14.9) | 19 (16.2) | 52 (14.3) | 71 (14.8) | 86 (14.8) |
| Treatment under GA (score = 4) | 15 (14.9) | 10 (8.6) | 34 (9.3) | 44 (9.1) | 59 (10.1) |
| Total | 101 | 117 | 364 | 481 | 582 |
| Mean score | 1.56 | 1.52 | 1.45 | 1.47 | 1.49 |
| Antibiotic score: | |||||
| No antibiotics (score = 0) | 40 (39.6) | 50 (42.7) | 138 (37.9) | 188 (39.1) | 228 (39.2) |
| Oral antibiotics and discharged (score = 1) | 33 (32.7) | 51 (43.6) | 149 (40.9) | 200 (41.6) | 233 (40.0) |
| IV antibiotics and discharged (score = 2) | 7 (6.9) | 4 (3.4) | 34 (9.3) | 38 (7.9) | 45 (7.7) |
| Admitted for IV antibiotics (score = 3) | 21 (20.8) | 12 (10.3) | 43 (11.8) | 55 (11.4) | 76 (13.1) |
| Total | 101 | 117 | 364 | 481‘ | 582 |
| Mean score | 1.09 | 0.81 | 0.95 | 0.92 | 0.95 |
| Sepsis six pathway: | |||||
| No (score = 0) | 98 (97.0) | 115 (98.3) | 354 (97.3) | 469 (97.5) | 567 (97.4) |
| Yes (score = 4) | 3 (2.9) | 2 (1.7) | 10 (2.8) | 12 (2.5) | 15 (2.6) |
| Total | 101 | 117 | 364 | 481 | 582 |
| Mean score | 0.12 | 0.07 | 0.11 | 0.10 | 0.1 |
| ITU admittance: | |||||
| No admittance to ITU (score = 0) | 100 (99.0) | 116 (99.2) | 359 (98.6) | 475 (98.8) | 575 (98.8) |
| Admitted to ITU (score = 5) | 1 (0.9) | 1 (0.9) | 5 (1.4) | 6 (1.2) | 7 (1.2) |
| Total | 101 | 117 | 364 | 481 | 582 |
| Mean score | 0.05 | 0.04 | 0.07 | 0.06 | 0.06 |
| Total mean score | 3.34 | 2.82 | 3.04 | 2.99 | 3.05 |
| Low severity score total (0–4) | 76 (75.2) | 99 (84.6) | 295 (81.0) | 394 (81.9) | 470 (80.8) |
| Moderate-severe severity score total (5–21) | 25 (24.8) | 18 (15.4) | 69 (19.0) | 87 (18.1) | 112 (19.2) |
| Total | 101 | 117 | 364 | 481 | 582 |
Chi-squared test comparing pre and post COVID-19 restrictions x2 = 2.8; p = 0.1; 1degree of freedom.
Fig. 3Bar chart to show pre admittance dental treatment across the study period.
Fig. 1Total Severity Score at each phase of primary dental care closure due to COVID-19 restrictions.
Fig. 2Total severity score across the Phase 1, 2 and 3 separated into Mild and Moderate-Severe Severity.